In this interview, Mabel Peters, who works with the UW Clinical Research Office as a clinical trials liaison, discusses her career path, and why diverse participation is so critical to the success of clinical trials....
UW Carbone Cancer Center is one of three research institutions in the United States participating in a breast cancer vaccine clinical trial and was the first to administer the vaccine to a participating patient....
The Circle of Trust is a new conceptual model that can help investigators and the American Indian/Alaska Natives (AI/AN) community work together to promote inclusion of AI/AN populations in clinical trials to improve health outcomes....
With today’s well-known workforce challenges, it is more important than ever for sites to address workforce development in a meaningful way, reimagining how clinical research departments perform in an organizational context....
National Institutes of Health (NIH) representatives state that international investment, collaboration, and coordination have been key to responding to the COVID-19 pandemic....
As the first generation of Alzheimer's disease drugs hits the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people. ...
The US Food and Drug Administration (FDA) has granted breakthrough therapy designation for Moderna’s investigational mRNA vaccine for respiratory syncytial virus (RSV) in adult patients....
Predictive analytics, the use of data, algorithms and visualizations to forecast outcomes, is being increasingly used in drug development and clinical trial design....
The NIH explores ways to speed up the research and discovery of new treatments for rare diseases, which are not often thought of as the public health challenge that they are. ...
Following a year filled with several approvals for rare disease drugs, experts are expecting this trend to continue in 2023....
